Kedudukan dalam Saham
#11593
CinCor Pharma, Inc. is an emerging biopharmaceutical firm in the clinical... CinCor Pharma, Inc. is an emerging biopharmaceutical firm in the clinical development phase, dedicated to pioneering therapeutic solutions for cardiovascular and renal conditions. At the core of its pipeline is CIN-107, an investigational compound currently undergoing Phase II clinical trials for indications such as hypertension, primary aldosteronism, and various other cardio-renal disorders. Additionally, CIN-107 is in Phase I clinical evaluation for its potential in treating chronic kidney diseases. The company holds a significant licensing agreement with F. Hoffman-La Roche Ltd. and Hoffmann-La Roche Inc. Established in 2018, CinCor Pharma, Inc. maintains its principal operations in Boston, Massachusetts.
Harga Saham
$29.06
Disegerakkan terakhir: 2023-02-23
Perubahan (1 hari)
-0.48%
Perubahan (1 tahun)
0.00%
Perdagangan CinCor Pharma, Inc. (CINC)
Harga CINC dengan permodalan pasaran b
Modal pasaran bagi CinCor Pharma, Inc.(CINC)
Modal Pasaran: $682.73M
Sehingga August 2026, CinCor Pharma, Inc. mempunyai modal pasaran sebanyak $682.73M. Ini menjadikan CinCor Pharma, Inc. syarikat ke-11593rd paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran CinCor Pharma, Inc. dari 2022 hingga 2026
CINC berbanding dengan 5 teratas yang paling popular stocks
| Harga CINC |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.264T
|
+770,907.55%
|
|
|
|
|
$4.701T
|
+688,503.78%
|
|
|
|
|
$4.177T
|
+611,738.24%
|
|
|
|
|
$3.817T
|
+559,041.15%
|
|
|
|
|
$2.866T
|
+419,737.17%
|
